Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV

NCT07673965 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV (Human Immunodeficiency Virus)
Sleep

Interventions

DRUG: Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Doravirine 100mg
DRUG: Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Dolutegravir 50mg

Sponsor

University of Witwatersrand, South Africa